Sign In
17 Feb 2020 07:00
FOR IMMEDIATE RELEASE | Monday 17 February, 2020 |
NMC HEALTH PLC
(the "Company")
Director resignation
The Company announces that Dr. B.R. Shetty has resigned as a director and Joint Non-Executive Chairman of the Company with immediate effect on 16 February 2020.
H.J. Mark Tompkins will continue as the sole Non-Executive Chairman of the Company.
Contacts
Investors
NMC Health plc | |
Simon Watkins, Group Company Secretary | +44 (0) 203 205 7313 |
Asjad Yayha, Head of Investor Relations | +971 (0) 56 219 0975 |
Media | |
FTI Consulting, London |
|
Edward Bridges / Simon Conway / Victoria Foster Mitchell | +44 (0)20 3727 1000 |
| |
FTI Consulting, Gulf |
|
Shane Dolan | +971 (0)4 437 2100 |
About NMC Health
NMC is one of the leading private healthcare operators in the Gulf Cooperation Council ("GCC") with an international network of multi-specialty inpatient and outpatient clinics and hospitals, specialized maternity and fertility clinics, and long-term care homes hospitals across nineteen countries. NMC also ranks as one of the top two in-vitro fertilisation operators globally. The NMC Health group is recognised as a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing a selective international expansion programme since 2016, NMC has total capacity of 2,207 licensed beds across its network. Moreover, the recent formation of a joint venture with GOSI/Hassana Investment Company provides a solid platform for continued growth in the GCC region's largest healthcare market. The NMC Health group treated over 7.5 million patients in 2018. The NMC Health group is also a leading UAE supplier of products and consumables coming from healthcare related products. NMC reported revenues of US$2.1 billion for the year ended 31 December 2018.
In April 2012, NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index.
Follow the stocks
